Related references
Note: Only part of the references are listed.Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression
Mariusz Papp et al.
BEHAVIOURAL PHARMACOLOGY (2017)
Differential Effects of an NR2B NAM and Ketamine on Synaptic Potentiation and Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy
David Nagy et al.
NEUROPSYCHOPHARMACOLOGY (2016)
The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature
Jenny Guidi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Continuation phase intravenous ketamine in adults with treatment resistant depression
Jennifer L. Vande Voort et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
D. Jeffrey Newport et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial
James W. Murrough et al.
NEUROPSYCHOPHARMACOLOGY (2015)
The Clinical Inadequacy of Evidence-Based Medicine and the Need for a Conceptual Framework Based on Clinical Judgment
Giovanni A. Fava et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2015)
Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
Paulo R. Shiroma et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression
Paulo R. Shiroma et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Decreased Occipital Cortical Glutamate Levels in Response to Successful Cognitive-Behavioral Therapy and Pharmacotherapy for Major Depressive Disorder
Chadi G. Abdallah et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
Imaging Patients with Psychosis and a Mouse Model Establishes a Spreading Pattern of Hippocampal Dysfunction and Implicates Glutamate as a Driver
Scott A. Schobel et al.
NEURON (2013)
Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression
Brian R. Cornwell et al.
BIOLOGICAL PSYCHIATRY (2012)
Subchronic ketamine treatment leads to permanent changes in EEG, cognition and the astrocytic glutamate transporter EAAT2 in mice
Robert E. Featherstone et al.
NEUROBIOLOGY OF DISEASE (2012)
Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study
Lobna Ibrahim et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Reduced Dorsal Prefrontal Gray Matter After Chronic Ketamine Use
Yanhui Liao et al.
BIOLOGICAL PSYCHIATRY (2011)
Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study
Celia J. A. Morgan et al.
ADDICTION (2010)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
Sanjay J. Mathew et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls
Celia J. A. Morgan et al.
ADDICTION (2009)
Patients' competence in and performance of cognitive therapy skills: Relation to the reduction of relapse risk following treatment for depression
Daniel R. Strunk et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2007)
Can cognitive behavioral therapy reduce relapse rates of depression after ECT? A preliminary study
Lisa Fenton et al.
JOURNAL OF ECT (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Cortical γ-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy
G Sanacora et al.
BIOLOGICAL PSYCHIATRY (2006)
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression
SD Hollon et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression
AJ Rush et al.
BIOLOGICAL PSYCHIATRY (2003)
The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals
A Collie et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2003)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
